Patient centricity is often overlooked in the early phases of drug development, even though it has been shown to significantly improve the outcomes of clinical trials for patients, investigators, and sponsors. Luckily, there are creative ways to approach patient centricity that make it not only feasible, but advantageous for early phase trials.

In this article, learn about five economical and efficient ways to make early phase trials both patient-centric and more effective.